$INTA | Intapp announces $150 million stock repurchase program https://t.co/VHX8WbpsUB
$INTA - Intapp announces fourth quarter and fiscal year 2025 financial results https://t.co/ivcn5TusdZ
$HRB | H&R Block Q4 2025 Earnings: EPS Miss, Revenue Beat; FY26 Guide Mixed; Dividend Hike Announced 📊 Q4 2025 Results: EPS (Non-GAAP): ❌ $2.27 vs $2.83 est. — miss by $0.56 Revenue: ✅ $1.11B vs $1.07B est. — +4.6% Y/Y 💰 Dividend Update: Quarterly dividend raised 12% to
Cardinal Health reported its fourth-quarter earnings for fiscal year 2025 with adjusted earnings per share (EPS) of $2.08, slightly above estimates of $2.04, and revenue of $60.16 billion, below the expected $60.92 billion. The company noted that revenue was relatively flat but increased 21% excluding the impact of a previously communicated contract expiration. GAAP operating earnings were $428 million with GAAP diluted EPS at $1.00. Despite raising its full-year 2026 adjusted EPS guidance to a range of $9.30 to $9.50, Cardinal Health's shares declined by 9.3% following the earnings release. H&R Block reported its fourth-quarter 2025 results with a non-GAAP EPS of $2.27, missing estimates by $0.56, while revenue rose 4.6% year-over-year to $1.11 billion, beating expectations. The company announced a 12% increase in its quarterly dividend. Intapp announced its fourth-quarter and fiscal year 2025 financial results, including a $150 million stock repurchase program.